Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
This application is a continuation-in-part of U.S. application Ser. No. 11/258,463, filed Oct. 25, 2005, which claims priority to U.S. provisional applications 60/623,252, filed Oct. 29, 2004, and 60/079,813, filed Mar. 30, 1998; all of which are hereby incorporated by reference as if written herein in their entirety.
